주요 내용으로 건너 뛰기
/ 자료 / 컨퍼런스 / Empowering Biotech and VC Innovation with Model-informed Drug Development (MIDD)

Empowering Biotech and VC Innovation with Model-informed Drug Development (MIDD)

In-person Event | Cambridge, MA

Join us for a dynamic roundtable discussion and networking event where venture capitalists (VCs) and VC-backed biotech leaders will share insights on how model-informed drug development (MIDD) and early and late-stage science-driven strategy can enhance decision-making and accelerate program success. 

Panelists:

  • Wojciech Dworakowski, PhD, Vice President, M&S, Toxicology and DMPK at Flagship Pioneering and Pioneering Medicines
  • Karen Hong, PhD​, Co-Founder and Co-Owner of Cold Spring Bio
  • Kevin Munnelly​, SVP of Technology at Third Rock Ventures
  • Alex Pellerin, PhD, Director at Seismic Therapeutic

Panelists will discuss:

  • Pain points at VCs and VC-backed biotechs and where MIDD and scientific consulting can help  
  • Certara’s cross-functional drug discovery and development expertise and application of MIDD solutions 
  • The benefits of a strategic partnership with Certara, including tech-enabled solutions and customized support to meet your development needs  
  • How investors are utilizing Certara’s solutions to support asset evaluation and prioritization 

Agenda:

5:00 – 5:30pm – Registration
5:30 – 5:40pm – Introduction
5:40 – 6:30pm – Industry panel discussion
6:30 – 7:00pm – Q&A session
7:00 – 8:00pm – Networking reception

행사장:

CIC Cambridge – 245 Main Street, Cambridge, MA 02142

Past Event
Powered by Translations.com GlobalLink Web Software